REVIEW
Published on 27 Sep 2022
Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
doi 10.3389/fonc.2022.970967
- 2,407 views
- 9 citations
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Insights in Cancer Molecular Targets and Therapeutics: 2022
Insights in Cancer Molecular Targets and Therapeutics: 2022
13k
Total downloads
40k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 02 Sep 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
doi 10.3389/fonc.2022.965261
- 2,485 views
- 8 citations
ORIGINAL RESEARCH
Published on 05 Aug 2022
Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors
doi 10.3389/fonc.2022.971594
- 1,993 views
- 3 citations
REVIEW
Published on 02 Jun 2022
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
doi 10.3389/fonc.2022.903016
- 10,275 views
- 62 citations
REVIEW
Published on 11 May 2022
LKB1: Can We Target an Hidden Target? Focus on NSCLC
doi 10.3389/fonc.2022.889826
- 5,280 views
- 12 citations
REVIEW
Published on 25 Mar 2022
Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer
doi 10.3389/fonc.2022.831949
- 7,295 views
- 30 citations
MINI REVIEW
Published on 08 Dec 2021
The Role of Immune Checkpoint Blockade in the Hepatocellular Carcinoma: A Review of Clinical Trials
doi 10.3389/fonc.2021.801379
- 3,086 views
- 22 citations
ORIGINAL RESEARCH
Published on 09 Jul 2021
The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma
doi 10.3389/fonc.2021.681441
- 3,899 views
- 18 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 40kTopic views
- 26kArticle views
- 13kArticle downloads